Processa Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.67
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.34
|
-0.37
|
-0.03
|
-8.82%
|
|
2022-06-30
|
-0.20
|
-0.32
|
-0.12
|
-60.00%
|
|
2022-03-31
|
-0.21
|
-0.20
|
0.01
|
4.76%
|
|
2021-12-31
|
-0.19
|
-0.21
|
-0.02
|
-10.53%
|
|
2021-09-30
|
-0.18
|
-0.19
|
-0.01
|
-5.56%
|
|
2021-06-30
|
-0.14
|
-0.20
|
-0.06
|
-42.86%
|
|
2021-03-31
|
-0.10
|
-0.14
|
-0.04
|
-40.00%
|
|
2020-12-31
|
-0.35
|
-1.69
|
-1.34
|
-382.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.89
|
|
2021-12-31
|
-0.74
|
|
2020-12-31
|
-2.53
|
|
2019-12-31
|
-0.71
|
|
2018-12-31
|
-0.71
|